Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Zarxio Countdown: Amgen Prepares To 'Compete Effectively' As Biosimilar Launch Looms

This article was originally published in The Pink Sheet Daily

Executive Summary

Last-ditch injunction request fails, and now pricing, reimbursement and naming (yes, still naming) are key questions.



Related Companies